Duloxetine

Product manufactured by Bryant Ranch Prepack

Application Nr Approved Date Route Status External Links
ANDA208706 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Duloxetine Delayed-Release Capsules Are Indicated For The Treatment Of: Major Depressive Disorder [see Clinical Studies ( 14.1 )] . Generalized Anxiety Disorder [see Clinical Studies ( 14.2 )] . Diabetic Peripheral Neuropathy [see Clinical Studies ( 14.3 )] . Chronic Musculoskeletal Pain [see Clinical Studies ( 14.5 )] . Duloxetine Delayed-Release Capsules Are A Serotonin And Norepinephrine Reuptake Inhibitor (snri) Indicated For: Major Depressive Disorder (mdd) ( 1 ) Generalized Anxiety Disorder (gad) ( 1 ) Diabetic Peripheral Neuropathic Pain (dpnp) ( 1 ) Chronic Musculoskeletal Pain ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Duloxetine Hydrochloride DULOXETINE HYDROCHLORIDE ZINC1536779

Comments